喉癌伴同时性或异时性肺癌患者预后列线图的开发与验证
本研究基于SEER数据库定义单独喉癌与喉癌伴同时或异时性肺癌(LCSMLC),用logistic回归筛选LCSMLC危险因素、Cox回归筛选独立预后因素并构建列线图,以Kaplan-Meier法检验风险分层,并与AJCC分期比较,另用两家中国独立机构61例患者进行外部验证。
要点
- 年龄、性别、种族、喉癌原发部位、分级和分期是LCSMLC的危险因素。
- 年龄、两癌间隔、病理类型、分期、手术、放疗、肺原发部位和喉原发部位是LCSMLC独立预后预测因素。
- 高、中、低风险分层在训练队列和验证队列中均显著区分LCSMLC患者预后。
核心结论
- 年龄、性别、种族、喉癌原发部位、分级和分期是LCSMLC的危险因素。
- 所构建并验证的个体化列线图预后预测模型对LCSMLC显示出更优的预测能力。
研究设计与样本
- 基于SEER数据库定义单独喉癌与LCSMLC,采用单因素和多因素logistic回归分析LCSMLC患者的危险因素,用Cox回归筛选独立预后因素并以R代码构建列线图。
- 训练队列纳入SEER数据库单独喉癌患者32429例和LCSMLC患者641例,外部验证队列纳入两家中国独立机构患者61例。
主要发现
- 与无同时或异时性肺癌的喉癌患者相比,年龄、性别、种族、喉癌原发部位、分级和分期是LCSMLC的危险因素,而婚姻状况、手术、放疗和化疗不是其危险因素。
- 年龄、两癌间隔、病理类型、分期、手术、放疗、肺原发部位和喉原发部位是LCSMLC的独立预后预测因素。
- 高、中、低风险分层系统在训练队列或验证队列中均显著区分不同LCSMLC患者的预后。
- 与第6版AJCC喉癌TNM分期相比,新的列线图和风险分层模型显示出改善的净获益。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The objective of this study was to examine the independent prognostic factors of laryngeal cancer with synchronous or metachronous lung cancer (LCSMLC), and to generate and verify a clinical prediction model. METHODS: In this study, laryngeal cancer alone and LCSMLC were defined using the Surveillance, Epidemiology, and End Results (SEER) database. Risk factors of patients with LCSMLC were analyzed through univariate and multivariate logistic regression analysis. Independent prognostic factors were selected by Cox regression analyses, on the basis of which a nomogram was constructed using R code. Kaplan-Meier survival analyses were applied to test the application of a risk stratification system. Finally, we conducted a comparison of the American Joint Committee on Cancer (AJCC) staging system of laryngeal cancer with the new model of nomogram and risk stratification. For further validation of the nomogram, data from patients at two Chinese independent institutions were also analyzed. RESULTS: According to the eligibility criteria, 32 429 patients with laryngeal cancer alone and 641 patients with LCSMLC from the SEER database (the training cohort) and additional 61 patients from two Chinese independent institutions (the external validation cohort) were included for final analyses. Compared with patients with laryngeal cancer who did not have synchronous or metachronous lung cancer, age, sex, race, primary site of laryngeal cancer, grade, and stage were risk factors for LCSMLC, while marriage, surgery, radiation therapy, and chemotherapy are not their risk factors. Age, two cancers' interval, pathological type, stage, surgery, radiation, primary lung site, and primary throat site were independent prognostic predictors of LCSMLC. The risk stratification system of high-, medium-, and low-risk groups significantly distinguished the prognosis in different patients with LCSMLC, regardless of the training cohort or the validation cohort. Compared with the 6th AJCC TNM stage of laryngeal cancer, the new model of nomogram and risk stratification showed an improved net benefit. CONCLUSIONS: Age, sex, race, primary site of laryngeal cancer, grade, and stage were risk factors for LCSMLC. An individualized clinical prognostic predictive model by nomogram was generated and validated, which showed superior prediction ability for LCSMLC.
引用
- Su H, Li H, Hou S, et al. Development and validation of a prognostic nomogram for patients with laryngeal cancer with synchronous or metachronous lung cancer. Head Neck. 2023. PMID: 37930037. doi:10.1002/hed.27550
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。